PRRT2 and metabolic disease: Oxidative stress can contribute to or worsen metabolic disorders resulting from hyperglycemia, such as heightened polyol and hexosamine pathways, activation of protein kinase C (PKC), and the formation of advanced glycation end products (AGEs).